Clinical efficacy and safety of convalescent plasma therapy for patients with SARS-CoV-2 infection

Clinical efficacy and safety of convalescent plasma therapy for patients with SARS-CoV-2 infection

Aim: to evaluate the efficacy and safety of convalescent plasma therapy for patients with severe SARS-CoV-2 infection.Materials and methods: the study included 64 patients with laboratory-confirmed severe new coronavirus infection. The control group consisted of 58 patients who, in addition to stand...

Full description

Bibliographic Details
Main Authors: D. V. Lavrenchuk, K. V. Zhdanov, K. V. Kozlov, O. V. Mal’cev, V. V. Gordienko, K. V. Kas’janenko, A. V. Kushnir, I. A. Vorob’jov, A. M. Ivanov, V. Nю Vil’janinov, M. E. Meshkova, Yu. V. Nikitin, E. B. Masalov
Format: Article
Language:Russian
Published: Journal Infectology 2022-04-01
Series:Журнал инфектологии
Subjects:
иммунная плазма
новая коронавирусной инфекция
covid-19
sars-cov-2
Online Access:https://journal.niidi.ru/jofin/article/view/1308

Internet

https://journal.niidi.ru/jofin/article/view/1308

Similar Items